Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
1,524,110
-
Shares change
-
-279,749
-
Total reported value, excl. options
-
$4,844,175
-
Value change
-
-$1,069,158
-
Number of buys
-
6
-
Number of sells
-
-15
-
Price
-
$3.18
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q3 2018
30 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q3 2018.
XBiotech Inc. - Common Shares, no par value (XBIT) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,524,110 shares
of 33,289,095 outstanding shares and own 4.58% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (834,523 shares), MILLENNIUM MANAGEMENT LLC (162,428 shares), GEODE CAPITAL MANAGEMENT, LLC (135,163 shares), BlackRock Inc. (87,407 shares), DIMENSIONAL FUND ADVISORS LP (45,659 shares), NORTHERN TRUST CORP (44,871 shares), ELEMENT CAPITAL MANAGEMENT LLC (30,184 shares), BlueCrest Capital Management Ltd (26,858 shares), CREDIT SUISSE AG/ (23,725 shares), and STATE STREET CORP (23,557 shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.